Previous studies [151, 152] have demonstrated that chronic activation of PKC-α diminished baseline ventricular ejection performance and, in combination with Gq-mediated hypertrophy, caused a lethal cardiomyopathy. This evidence concerns the gene PRKCA and hypertrophy.